GENFIT signs royalty financing deal with HealthCare Royalty (HCRx) providing up to €185 million non-dilutive capital: €130 million upfront, with eligibility to receive up to €55 million in two additional instalments based on near-term milestones Closing subject to approval by the 2025 OCEANE bondholders at upcoming bondholders meeting Financing would extend cash runway beyond the end of 2027, assuming drawdown of all instalments Proceeds to further strengthen the development of the ACLF pipelineIn return, HCRx will receive a portion of royalties on global1 sales of Iqirvo® (elafibranor) payable to GENFIT under its licensing agreement with Ipsen, up to an agreed upon cap after which all future royalties will revert back to GENFIT GENFIT retains rights to all future regulatory, commercial and sales-based milestone payments from Ipsen...

IRVINE, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) — Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the pricing of its upsized initial public offering of 12,000,000 shares of common stock at a price to the public of $17.00 per share. The gross proceeds to Beta Bionics from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Beta Bionics, are expected to be $204.0 million. In addition, the underwriters have a 30-day option to purchase up to an additional 1,800,000 shares of common stock at the public offering price, less underwriting discounts and commissions, consisting of 475,000 shares from Beta Bionics and 1,325,000 shares from the selling stockholders named in the prospectus. Beta Bionics will not receive any...

VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) — Imperial Metals Corporation (the “Company” or “Imperial”) (TSX:III) reports that 2024 metal production from Mount Polley was 35.7 million pounds of copper and 39,108 ounces of gold. The mine met its targets of 34–37 million pounds for copper production and 37-41 thousand ounces for gold production. Red Chris production will be released when the reconciled information is received from Newmont Corporation. Mount Polley Mine – Production During the fourth quarter 1,660,937 tonnes of ore were treated (up 6% compared to Q4 2023). During the quarter 9.242 million pounds copper (up 11% from Q4 2023) and 9,564 ounces gold (down 7.6% from Q4 2023) were produced.Mount Polley Mine Production Three Months Ended December 31   Year Ended December 31    2024 2023   2024 2023  Ore...

Monte Alto depositMonte Alto deposit with high-grade monazite sands overlaying the hard rock REE-Nb-Sc-Ta-U mineralisation – Oblique View to the SouthwestSYDNEY, Jan. 29, 2025 (GLOBE NEWSWIRE) — Brazilian Rare Earths Limited (ASX:BRE / OTCQX: BRELY) (‘BRE’) is pleased to provide its quarterly report for the period ended 31 December 2024. Key highlights during and subsequent to the end of the quarter included: Record Exploration Success Continues at Monte AltoUltra-high-grade rare earth intercepts up to 45.7% TREO, with standout grades of NdPr (69,558 ppm) and DyTb (11,696 ppm) New record assays for niobium (1.7% Nb2O5) and tantalum (962 ppm Ta2O5) with very-high grades of scandium (382 ppm Sc2O3) and uranium (5,781 ppm U3O8) Exploration increased the continuity, depth and scale of the ultra-high-grade REE-Nb-Sc-Ta-U...

CHARLOTTE, N.C., Jan. 29, 2025 (GLOBE NEWSWIRE) — Magnera (NYSE: MAGN) expects to release its 2025 first quarter results prior to trading on the New York Stock Exchange on Thursday, February 6, 2025. The earnings release will be available shortly thereafter on Magnera’s website at www.Magnera.com. In conjunction with its release, Magnera’s Executive team will hold a conference call to discuss the 2025 first quarter financial results at 10:00am (ET) on Thursday, February 6, 2025. What: 2025 Q1 Magnera Financial Results, Q&A and Webcast When: Thursday, February 6, 2025Time: 10:00 a.m. ETTelco:  Pre-register (click here to receive dial-in and unique pin for Q&A)Webcast: Listen in option (live and replay) Approximately two hours after the Q&A session, an archived version of the webcast will be available on the Company’s...

FREMONT, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) — Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, today announced it will release financial results for the fourth quarter and full year 2024 on Wednesday, February 19, 2025, after the close of the market. Enovix will hold a live video call at 2:00 PM PT / 5:00 PM ET on February 19, 2025, to discuss the company’s business updates, key milestones, and financial results. To join the call, participants must use the following link to register: https://enovix-q4-2024.open-exchange.net/. This link will also be available via the Investor Relations section of Enovix’s website at https://ir.enovix.com. Investors may also submit questions on the registration page that they would like addressed on the call by Enovix management. An archived version of...

ACHESON, Alberta, Jan. 29, 2025 (GLOBE NEWSWIRE) — North American Construction Group Ltd. (“NACG” or “the Company”) (TSX:NOA/NYSE:NOA) announced today that it has delivered notice to the holders of the Company’s outstanding 5.5% convertible unsecured subordinated debentures due June 30, 2028 (the “Debentures”) that pursuant to Section 4.3 of the trust indenture governing the Debentures dated June 1, 2021 (the “Trust Indenture”), the Company will, effective February 28, 2025 (the “Redemption Date”), redeem all issued and outstanding Debentures, plus accrued interest thereon. In accordance with the Trust Indenture, holders of these Debentures may convert the outstanding Debentures into common shares of the Company at a price of $24.23 per share, which is at a discount to the closing price of NACG’s common shares of $28.45 per share...

Cayman Islands, January 29, 2025 — Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 2,221,523 of the Company’s ordinary shares originally issued in January 2025 having an exercise price of $1.35 per share. The ordinary shares issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (No. 333-282932). The gross proceeds to the Company from the exercise of the warrants are expected to be approximately $3.3 million, prior to deducting placement agent fees and estimated offering expenses. The offering is...

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority) Sanofia French société anonyme with a registered share capital of 2,526,245,442 €Registered office : 46, avenue de la Grande Armée – 75017 Paris – FranceRegistered at the Paris Commercial and Companies Registry under number 395 030 844DateTotal number of issued sharesNumber of real voting rights(excluding treasury shares) Theoretical number of voting rights (including treasury shares)*December 31, 2024 1,263,122,721 1,413,130,110 1,422,661,191* Pursuant to article 223-11 of the Règlement général de l’Autorité des Marchés Financiers. This...

NEW YORK, NY, Jan. 29, 2025 (GLOBE NEWSWIRE) — Plum Acquisition Corp. IV. (Nasdaq: PLMKU) (the “Company”) today announced that, commencing on January 31, 2025, holders of the units (the “Units”) sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares (the “Ordinary Shares”) and warrants (the “Warrants”) included in the Units. The Ordinary Shares and Warrants received from the separated Units will trade on the Nasdaq Global Market (“Nasdaq”) under the symbols “PLMK” and “PLMKW”, respectively. Units that are not separated will continue to trade on Nasdaq under the symbol “PLMKU”. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. Holders of Units will need to have their brokers contact Continental Stock Transfer & Trust...